Betaval 0.1 g cream 20 g

Trade Name:

Betaval cream

Betamethasone 0.1 g

20 г

Composition:

Each 100 g of cream contains:

Betamethasone 0.1 g

Inactive ingredients:

Catosterol, white soft paraffin, propylene glycol, liquid paraffin, glyceryl monostearate, methyl parahydroxybenzoate, 

Properties:

Betamethasone is a synthetic fluorinated corticosteroid for use in dermatology and has strong anti-inflammatory, antipruritic and vasoconstrictive effects. The mechanism of betamethasone’s anti-inflammatory action is not fully understood. It is believed that this drug reduces inflammatory processes by inhibiting the production of prostaglandins and leukotrienes due to inhibition of phospholipase A2 activity and reducing the release of arachidonic acid from phospholipids of cell membranes. As a result, hyperemia and exudation in the focus of the lesion are reduced.

Indications:

For the treatment of skin diseases amenable to GCS therapy in the presence of secondary bacterial infection or the likelihood of its development:

-eczema;

-atopic dermatitis;

-neurodermatitis;

-contact dermatitis (including occupational);

-allergic dermatitis;

-psoriasis;

-red squamous lichen planus;

-seborrheic dermatitis;

-exfoliative dermatitis;

-radiation dermatitis.

-infected dermatitis developed as a result of insect bites, scabies and diaper rash.

Directions for use:

-The drug is used externally.

-Cream is applied to the affected area of the skin in a thin layer, gently rubbing, 1-2 times / day. In areas with thicker skin (e.g. elbows, palms, feet), as well as areas where the drug is easily rubbed off, the drug can be applied more often, but not more than 4 times/day.

-The necessary frequency of application should be established by a physician, based on the severity of the disease. In mild cases, application once/day is usually sufficient, in more severe lesions more frequent application may be required.

-The duration of treatment depends on the degree of severity, localization of lesions and the patient’s response to treatment. In the treatment of chronic diseases, therapy should be continued for 3-7 days after the disappearance of all symptoms. 

-The duration of treatment should not exceed 2-4 weeks.

Side effects:

Skin and subcutaneous tissues: burning, itching, irritation, dry skin, folliculitis, hypertrichosis, steroidal acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, telangiectasia, skin maceration, skin atrophy, stretch marks, miliaria, secondary skin infections, pigmentation changes, hair pigmentation. Rash, itching, edema, erythema and other signs of skin irritation.

Contraindications:

Hypersensitivity to betamethasone, or to any of the excipients of the drug, or glucocorticoids;

-chickenpox;

-fungal skin diseases;

-viral skin infections (herpes simplex, shingles);

-open wounds;

-acne, rosacea;

-perioral dermatitis;

-atrophy of the skin;

-perianal and genital itching;

-pregnancy (prolonged treatment of large areas of skin);

Warnings and precautions:

-If signs of hypersensitivity or skin irritation occur during use of the drug, the patient should discontinue treatment and consult a physician.

Storage:

Store in a cool dry place at a temperature not exceeding 30°C.

Package:

Carton box holds a tube of 20 g, paper instructions.